HS2
vs
A
0HF3
HS2
Over the past 12 months, HS2 has underperformed 0HF3, delivering a return of -17% compared to the 0HF3's +44% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
HS2
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Henry Schein Inc
F:HS2
|
63.6
EUR
|
|||||
|
A
|
Amerisourcebergen Corp
LSE:0HF3
|
356.2
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
HS2, 0HF3
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Henry Schein Inc
Revenue
|
|||||||||||
|
A
|
Amerisourcebergen Corp
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
HS2, 0HF3
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Henry Schein Inc
F:HS2
|
|||||||||
|
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Henry Schein Inc | ||||
|
A
|
Amerisourcebergen Corp | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Henry Schein Inc | ||||
|
A
|
Amerisourcebergen Corp | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
HS2, 0HF3
Performance Gap
HS2, 0HF3
Performance By Year
HS2, 0HF3
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Mckesson Corp
NYSE:MCK
|
|
| US |
|
Cencora Inc
NYSE:COR
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
|
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|